Effects of four antiepileptic drugs on sleep and waking in the rat under both light and dark phases

被引:13
作者
Bertorelli, R
Ferri, N
Adami, M
Ongini, E
机构
[1] Research Laboratories, Schering-Plough, I-20060 Comazzo, Milan
关键词
anticonvulsant drugs; felbamate; lamotrigine; carbamazepine; phenobarbital; sleep-wake cycle; rat;
D O I
10.1016/0091-3057(95)02050-0
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Sedation is a common side effect of anticonvulsant drug therapy. To find out whether the new antiepileptic drugs, felbamate and lamotrigine, are able to produce sedation, we carried out electroencephalographic (EEG) studies in the rat to measure drug effects on sleep-wake patterns, during both light and dark phases. For comparison, the reference drugs, carbamazepine and phenobarbital, were also studied. EEG activity was recorded for 6 h after oral (PO) administration of drugs or vehicle, and the stages of wakefulness, rapid eye movements (REM) sleep and non-REM sleep were classified thereafter. In the light phase, felbamate (30-300 mg/kg) did not produce sedative effects, while lamotrigine (3-30 mg/kg) increased wakefulness at each dose tested. Carbamazepine (10-100 mg/kg) did not produce sleep-wake alterations, and phenobarbital (100 mg/kg) markedly suppressed REM. In the dark phase, felbamate (300 mg/kg), lamotrigine (30 mg/kg), and carbamazepine (100 mg/kg) reduced REM but did not change the total amount of sleep. Phenobarbital, at 100 mg/kg, markedly increased total sleep and greatly reduced REM. This study shows that the anticonvulsant drugs examined have different effects on the states of sleep and wakefulness in the rat. The data are discussed on the basis of the mechanism of action that characterizes each individual drug.
引用
收藏
页码:559 / 565
页数:7
相关论文
共 40 条
[1]  
[Anonymous], SLEEP EPILEPSY
[2]   EVIDENCE FOR A SPECIFIC ROLE FOR CORTICAL NMDA RECEPTORS IN SLOW-WAVE SLEEP [J].
ARMSTRONGJAMES, M ;
FOX, K .
BRAIN RESEARCH, 1988, 451 (1-2) :189-196
[3]  
BETTS T, 1991, EPILEPSIA S2, V32, P17
[4]   EPILEPSY - FELBAMATE - A NEW ANTIEPILEPTIC DRUG [J].
BRODIE, MJ .
LANCET, 1993, 341 (8858) :1445-1446
[5]   LAMOTRIGINE [J].
BRODIE, MJ .
LANCET, 1992, 339 (8806) :1397-1400
[6]   HYPNOTIC ACTION OF PENTOBARBITAL IN MICE - A POSSIBLE MECHANISM [J].
CHWEH, AY ;
SWINYARD, EA ;
WOLF, HH .
EXPERIMENTAL NEUROLOGY, 1987, 97 (01) :70-76
[7]   SELECTIVE ANTAGONISM OF THE ANTICONVULSANT EFFECTS OF FELBAMATE BY GLYCINE [J].
COFFIN, V ;
COHENWILLIAMS, M ;
BARNETT, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 256 (02) :R9-R10
[8]   EXCITATORY AMINO-ACID NEUROTRANSMISSION THROUGH BOTH NMDA AND NON-NMDA RECEPTORS IS INVOLVED IN THE ANTICONVULSANT ACTIVITY OF FELBAMATE IN DBA/2 MICE [J].
DESARRO, G ;
ONGINI, E ;
BERTORELLI, R ;
AGUGLIA, U ;
DESARRO, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 262 (1-2) :11-19
[9]   FELBAMATE DISPLAYS IN-VITRO ANTIEPILEPTIC EFFECTS AS A BROAD-SPECTRUM EXCITATORY AMINO-ACID RECEPTOR ANTAGONIST [J].
DOMENICI, MR ;
SAGRATELLA, S ;
ONGINI, E ;
LONGO, R ;
DECAROLIS, AS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 271 (2-3) :259-263
[10]  
FEINBERG I, 1994, NEUROPSYCHOPHARMACOL, V9, P41